Elizabeth A.Robertson (Liz)

For over 25 years, Liz Robertson has helped international clients develop, exploit, and acquire new technologies. Her practice centers on technology and IP developments across many sectors, with a focus on the financial services and pharmaceutical and health care industries. She works strategically with clients to derive value through M&A transactions and through sophisticated commercial agreements. Liz has extensive experience with software licensing, outsourcing, trademark and branding, agency and distribution, development, franchising, collaboration, joint venture, and nondisclosure agreements. Her regulatory work includes advising on data protection, antibribery and corruption, cybersecurity, export control, pharmaceutical marketing, MIFID (Markets in Financial Instruments Directive) outsourcing, and employee transfers. She has worked on internal investigations and compliance reviews for clients in the pharmaceutical sector.

Over the years, Liz has worked on numerous IT and pharma transactions for AstraZeneca, Blackberry, Cardinal Health, Diebold, and STERIS, as well as on technical/implementation issues arising from outsourcings by Fortune 500 clients. During her career she has enjoyed secondments with STERIS, Jefferies, and Bank of America Merrill Lynch. She is a regular speaker at client briefings on technology, licensing, and commercial contract issues.

For many years Liz has assisted UK charities, including the Royal Academy of Arts, Shift.ms, and The Brittle Bones Society, on commercial contracts and charity regulation issues.

Liz began her career in Jones Day's New York Office in 1988, transferring to the Firm's London Office in 1990.